Trade Summary

4 days ago, Xu Zhenyu, serving as Chief Scientific Officer at SOPHiA GENETICS SA (SOPH), sold 7,393 shares at $5.17 per share, for a total transaction value of $38,241.77. Following this transaction, Xu Zhenyu now holds 614,887 shares of SOPH.

This sale represents a 1.19% decrease in Xu Zhenyu's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, July 6, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, July 7, 2026 at 4:03 PM ET, 1 day after the trade was made.

SOPHiA GENETICS SA operates in the HEALTHCARE sector, specifically within the HEALTH INFORMATION SERVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.